Stanton Rowe
NXT Biomedical
Irvine,
CA
USA
Biographical Sketch:
Mr. Stanton J. Rowe is CEO of the NXT Biomedical and was Chief Scientific Officer of Edwards Lifesciences. since 2008 and served as its Corporate Vice President of Advanced Technology. He was Founded and CEO of Percutaneous Valve Technologies (sold to Edwards), which developed the first TAVR..
He served as the Corporate VP of Business Development at Datascope Corp. Prior to this, Mr. Rowe served as a VP of Business Development at Johnson & Johnson’s Interventional Systems Division, responsible for J&Js coronary stent development efforts. At JJIS and the related Cordis Corporation, he held a variety of positions with increasing levels of responsibility, including heading J&J’s Business Development, Advanced Technology, Worldwide Clinical Research and Marketing groups.
He serves as a Director of NovaSignal, and Anuncia. Mr. Rowe also is a Director for the Discovery Science Center. He holds a Bachelor’s Degree and a D.Sc.(honoris) from the University of Alabama.
Papers: